Cisema is delighted to give a presentation with the FORUM Institut on June 4-5, 2024. The total 6 hours of live webcast will help you learn more about market potential and product approval. Our Cisema experts will provide you with comprehensive information – especially on the subject of approval and risks that exist for European medical device manufacturers or importers.
Topics
- Market potential for European companies in the Chinese market
- Product approval
- National Medical Products Administration (NMPA): Documents, procedures, fees – tips and tricks
- Clinical pathways
- Post-market Surveillance & Quality Management System
- Latest Regulatory Changes and Trends
Target audiences
This course is aimed at specialists and managers in the medical device and IVD industry who are planning medical device marketing or renewing an existing marketing authorization in China. This online training is of particular interest for the following departments:
- Regulatory, clinical and quality affairs
- Strategy & corporate development
- Marketing and product management
- Distribution and sales
Key benefits
- Highlighting opportunities and potential of European medical devices and technology in the Chinese market.
- Detailed description of requirements for the registration of medical devices in China.
- Insight into regulatory novelties in China.
- Opportunity to learn about significant regulatory factors for European medical device manufacturers.
- Direct interaction with local experts during Q&A sessions.
Details
Date: June 4-5, 2024 (Tuesday & Wednesday)
Time: 9-12 AM CET
Language: English
Speakers
Stefan Fischer
Cisema (Hong Kong) Limited
Founder & Managing Director
Hamish King
Cisema (Hong Kong) Limited
CEO
Guo Ning
Cisema Beijing
General Manager, Beijing
Further information
If you want to know more about Market Potential and Product Approval in China, please discover our services for medical device registration, renewals and NMPA Legal Agent or learn more about our upcoming events.
